Suchergebnisse - "Zettl, Florian"

PubPharm (24)

1

First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma : Results of the B-R-ENDA Trial

enthalten in: HemaSphere | 2022

von Braulke, F. | Zettl, F. | Ziepert, M. | +18

2

First-line treatment with bendamustine and rituximab for old and frail patients with aggressive lymphoma : results of the B-R-ENDA trial

enthalten in: HemaSphere | Dec 1, 2022

von Braulke, F. | Zettl, F. | Ziepert, M. | +18

3

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma : analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma-data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin's Lymphoma Study Group)

enthalten in: Annals of hematology | 2021

von Zettl, F. | Ziepert, M. | Altmann, B. | +9

4

Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study

enthalten in: Haematologica | 2021

von Morschhauser, F. | Bouabdallah, K. | Stilgenbauer, S. | +13

5

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma : the DSHNHL2006-1B/ACT-2 trial

enthalten in: Leukemia | 2021

von Wulf, G. | Altmann, B. | Ziepert, M. | +26

6

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)

enthalten in: Annals of hematology | 2020

von Zettl, F. | Ziepert, M. | Altmann, B. | +9

7

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)

enthalten in: Annals of hematology | 2020

von Zettl, F. | Ziepert, M. | Altmann, B. | +9

8

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)

enthalten in: Annals of hematology | 2020

von Zettl, F. | Ziepert, M. | Altmann, B. | +9

9

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Blood | 2016

von Viardot, A. | Goebeler, M. | Hess, G. | +10

10

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Blood | 2016

von Viardot, A. | Goebeler, M. | Hess, G. | +10